Cercar
01/10/2025
SERUM FROM SYMPTOMATIC AND ASYMPTOMATIC PATIENTS WITH CAROTID ATHEROSCLEROSIS INDUCES ENDOTHELIAL DYSFUNCTION
García-Aranda, J, Camps-Renom, P, Puig, N, Pérez, B, Rodríguez, C, Martínez, J, Benitez, S, Jiménez-Altayó, F. SERUM FROM SYMPTOMATIC AND ASYMPTOMATIC PATIENTS WITH CAROTID ATHEROSCLEROSIS INDUCES ENDOTHELIAL DYSFUNCTION. International Journal of Stroke. 2025; 20DOI:. PMID:. IF:8.700(Q1/1D).
01/11/2023
LDL binding to cell receptors and extracellular matrix is proatherogenic in obesity but improves after bariatric surgery.
Jayaraman S, Pérez A, Miñambres I, Sánchez-Quesada JL, Gursky O. LDL binding to cell receptors and extracellular matrix is proatherogenic in obesity but improves after bariatric surgery.. JOURNAL OF LIPID RESEARCH. 2023; 64(11)DOI:10.1016/j.jlr.2023.100451. PMID:37777014. IF:5.000(Q1/3D).
20/09/2023
Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis.
Puig N, Solé A, Aguilera-Simon A, Griñán R, Rotllan N, Camps-Renom P, Benitez S. Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis.. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(18)DOI:10.3390/ijms241814325. PMID:37762627. IF:4.900(Q1/3D).
07/12/2025
Multidisciplinary meetings to provide the best cardiovascular care: the European Society for Clinical Investigation
Liberale, L, Vilahur, G, Carbone, F. Multidisciplinary meetings to provide the best cardiovascular care: the European Society for Clinical Investigation. EUROPEAN HEART JOURNAL. 2025; 46(46)DOI:10.1093/eurheartj/ehaf739. PMID:41078253. IF:35.600(Q1/1D).
01/06/2025
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis
Paradies, V, Masiero, G, Rubboli, A, Van Beusekom, HMM, Costa, F, Capranzano, P, Degrauwe, S, Gorog, DA, Jorge, CM, Buchanan, GL, Alasnag, M, Trabattoni, D, Fraccaro, C, Sibbing, D, Dudek, D, Vilahur, G, Chieffo, A, Mehran, R, Capodanno, D, Barbato, E, Siller-Matula, JM. Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis. EuroIntervention. 2025; 21(12)DOI:10.4244/EIJ-D-24-00876. PMID:40388110. IF:9.500(Q1/1D).
01/05/2025
Functional bone marrow transplantation into metabolically altered rats enhances cardiac recovery post myocardial infarction and ameliorates lipid profile
Ramos-Regalado, L, Alcover, S, Padró, T, Sancho, G, Badimon, L, Balart, J, Vilahur, G. Functional bone marrow transplantation into metabolically altered rats enhances cardiac recovery post myocardial infarction and ameliorates lipid profile. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2025; 55DOI:. PMID:. IF:3.600(Q1/2D).
01/05/2025
RUNX2 and atherosclerotic cardiovascular disease presentation in genetically diagnosed familial hypercholesterolemia
Escate, R, Jimenez, FF, Vilahur, G, Cepeda, JM, Mata, P, Badimon, L, Padro, T. RUNX2 and atherosclerotic cardiovascular disease presentation in genetically diagnosed familial hypercholesterolemia. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2025; 55DOI:. PMID:. IF:3.600(Q1/2D).
01/05/2025
Superiority of intravenous statin during STEMI over oral loading: A CMR preclinical cardioprotection study
Otero, S, Arzanauskaite, M, Ben-Aicha, S, Mendieta, G, Gutiérrez, M, Sutelman, P, Borrell-Pages, M, Hidalgo, A, Badimon, L, Vilahur, G. Superiority of intravenous statin during STEMI over oral loading: A CMR preclinical cardioprotection study. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2025; 55DOI:. PMID:. IF:3.600(Q1/2D).
01/05/2025
Diabetic patients with severe atherosclerosis display an exacerbated trained immune response characterized by an immunometabolic switch towards a prooxidative profile
Girón, G, Padró, T, Guala, A, Fernández, R, Garcia-Elias, A, Borrell-Pagés, M, Oliveró, R, Martín-Grieve, S, Badimon, L, Maceira, A, Rodríguez-Palomares, JF, Vilahur, G. Diabetic patients with severe atherosclerosis display an exacerbated trained immune response characterized by an immunometabolic switch towards a prooxidative profile. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2025; 55DOI:. PMID:. IF:3.600(Q1/2D).
01/05/2025
Diabetic patients with atherosclerosis display a pro-atherogenic proteomic signature within the plasma-enriched high-density lipoprotein fraction
Girón, G, Padró, T, Guala, A, Fernández, R, Garcia-Elias, A, Borrell-Pagés, M, Oliveró, R, Martin-Grieve, S, Badimon, L, Maceira, A, Rodríguez-Palomares, JF, Vilahur, G. Diabetic patients with atherosclerosis display a pro-atherogenic proteomic signature within the plasma-enriched high-density lipoprotein fraction. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2025; 55DOI:. PMID:. IF:3.600(Q1/2D).
01/05/2025
Proton nuclear magnetic resonance characterization of lipoprotein particles in subjects with overweight and obesity
Santisteban, V, López-Yerena, A, Muñoz-Garcia, N, Vilahur, G, Badimon, L, Padro, T. Proton nuclear magnetic resonance characterization of lipoprotein particles in subjects with overweight and obesity. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2025; 55DOI:. PMID:. IF:3.600(Q1/2D).
01/12/2023
Bioinformatic platforms for clinical stratification of natural history of atherosclerotic cardiovascular diseases.
Benincasa G, Suades R, Padrò T, Badimon L, Napoli C. Bioinformatic platforms for clinical stratification of natural history of atherosclerotic cardiovascular diseases.. European Heart Journal-Cardiovascular Pharmacotherapy. 2023; 9(8)DOI:10.1093/ehjcvp/pvad059. PMID:37562936. IF:(Q/D).
01/11/2023
The efficacy of intensive lipid-lowering therapies on the reduction of LDLc and of major cardiovascular events.
Cordero A, Fernández Olmo R, Badimon L, Santos-Gallego CG, Castellano JM, Fácila L, Rodriguez-Manero M, Bonanad C, Vilahur G, Escribano D, Badimon JJ, González-Juanatey JR. The efficacy of intensive lipid-lowering therapies on the reduction of LDLc and of major cardiovascular events.. Journal of Clinical Lipidology. 2023; 17(5)DOI:10.1016/j.jacl.2023.08.006. PMID:37775463. IF:3.600(Q2/3D).
01/01/2026
Atherogenic dyslipidaemia and residual cardiovascular risk: Understanding the link to heart disease
Girón, GO, Otero, S, Nikolaou, PE, Alcover, S, Ramos-Regalado, L, Zaragoza, C, Liberale, L, Borrell-Pages, M, Padró, T, Suades, R, Vilahur, G. Atherogenic dyslipidaemia and residual cardiovascular risk: Understanding the link to heart disease. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2026; 56(1)DOI:10.1111/eci.70167. PMID:41482986. IF:3.600(Q1/2D).
01/05/2025
Canonical WNT pathway role in heart-brain axis after myocardial
Pimentel, N, Luquero, A, Vilahur, G, Borrel-Pages, M. Canonical WNT pathway role in heart-brain axis after myocardial. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2025; 55DOI:. PMID:. IF:3.600(Q1/2D).
01/01/2026
miRNA Expression Profile in Whole Blood of Healthy Volunteers and Moderate Beer Consumption with Meals
Padro, T, Escate, R, Badimon, L. miRNA Expression Profile in Whole Blood of Healthy Volunteers and Moderate Beer Consumption with Meals. Nutrients. 2026; 18(1)DOI:10.3390/nu18010149. PMID:41515265. IF:5.000(Q1/2D).
27/12/2025
Lipoprotein-Specific Fatty Acid Profiles in Familial Hypercholesterolemia: Associations with Cardiovascular History and Dietary Patterns
López-Yerena, A, Arroyo-Olivares, R, Santisteban, V, Muñoz-Garcia, N, Estruch, R, Mata, P, Badimon, L, Padro, T. Lipoprotein-Specific Fatty Acid Profiles in Familial Hypercholesterolemia: Associations with Cardiovascular History and Dietary Patterns. Nutrients. 2025; 18(1)DOI:10.3390/nu18010092. PMID:41515209. IF:5.000(Q1/2D).
28/01/2026
A novel methodology to characterize beat-to-beat alternations in whole-cell calcium currents
Marimon, X, Cerrolaza, M, Tarifa, C, Hove-Madsen, L. A novel methodology to characterize beat-to-beat alternations in whole-cell calcium currents. PLoS One. 2026; 21(1)DOI:10.1371/journal.pone.0339890. PMID:41604389. IF:2.600(Q2/4D).
01/12/2025
Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference
Svennberg, E, Merino, JL, Andrade, J, Anselmino, M, Arbelo, E, Boersma, E, Boriani, G, Breithardt, G, Chung, MN, Chyou, J, Cohen, A, Nielsen, JC, Dichtl, W, Diederichsen, SZ, Dobrev, D, Doehner, W, Dworatzek, E, Fabritz, L, Filgueiras-Rama, D, Gimpelewicz, C, Hack, G, Hatem, S, Healey, J, Heidbuchel, H, Hijazi, Z, Holst, AG, Hove-Madsen, L, Jalife, J, van Leerdam, R, Linz, D, Lip, GYH, Lubitz, S, de Melis, M, Meyer, R, Orczykowski, M, Parwani, AS, Porta-Sanchez, A, de Potter, T, Ravens, U, Rienstra, M, Rillig, A, Rivard, L, Scherr, D, Schnabel, RB, Schotten, U, Simovic, S, Sinner, M, Sohns, C, Sommer, P, Steinbeck, G, Steven, D, Sultan, A, Thomalla, G, Toennis, T, Tzeis, S, Voigt, N, Wadhwa, M, Wakili, R, Witt, H, Goette, A, Kirchhof, P. Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference. EUROPACE. 2025; 27(12)DOI:10.1093/europace/euaf318. PMID:41392710. IF:7.400(Q1/2D).
16/01/2025
A Homozygous ATP2A2 Variant Alters Sarcoendoplasmic Reticulum Ca2+-ATPase 2 Function in Skeletal Muscle and Causes a Novel Vacuolar Myopathy
Llansó, L, Ravenscroft, G, Aceituno, C, Gutiérrez, A, Parmar, J, Gallano, P, Caballero-avila, M, Carbayo, A, Vesperinas, A, Collet, R, Blanco, R, Laing, N, Hove-Madsen, L, Gallardo, E, Olivé, M. A Homozygous ATP2A2 Variant Alters Sarcoendoplasmic Reticulum Ca2+-ATPase 2 Function in Skeletal Muscle and Causes a Novel Vacuolar Myopathy. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2025; 51(1)DOI:10.1111/nan.70000. PMID:39817497. IF:3.400(Q1/3D).
01/12/2021
Using hiPSC-CMs to Examine Mechanisms of Catecholaminergic Polymorphic Ventricular Tachycardia.
Arslanova A, Shafaattalab S, Ye K, Asghari P, Lin L, Kim B, Roston TM, Hove-Madsen L, Van Petegem F, Sanatani S, Moore E, Lynn F, Søndergaard M, Luo Y, Chen SRW, Tibbits GF. Using hiPSC-CMs to Examine Mechanisms of Catecholaminergic Polymorphic Ventricular Tachycardia.. Current Protocols. 2021; 1(12)DOI:10.1002/cpz1.320. PMID:34958715. IF:(Q/D).
01/11/2025
Targeting LDL aggregation decreases atherosclerotic lipid burden in a humanized mouse model of familial hypercholesterolemia: Crucial role of ApoB100 conformational stabilization
Benitez-Amaro, A, Garcia, E, Lhoëst, MTL, Martínez, A, Borrás, C, Tondo, M, Céspedes, MV, Caruana, P, Pepe, A, Bochicchio, B, Cenarro, A, Civeira, F, Prades, R, Escola-Gil, JC, Llorente-Cortés, V. Targeting LDL aggregation decreases atherosclerotic lipid burden in a humanized mouse model of familial hypercholesterolemia: Crucial role of ApoB100 conformational stabilization. ATHEROSCLEROSIS. 2025; 410DOI:10.1016/j.atherosclerosis.2024.118630. PMID:39547850. IF:5.700(Q1/1D).
01/11/2023
Relationship between transcriptional expression of pyruvate dehydrogenase and local control of disease in patients with oral cavity carcinomas.
León X, Bagué S, Holgado A, Quer M, Terra X, Camacho M, Avilés-Jurado FX. Relationship between transcriptional expression of pyruvate dehydrogenase and local control of disease in patients with oral cavity carcinomas.. Acta Otorrinolaringologica Espanola. 2023; 74(6)DOI:10.1016/j.otoeng.2023.05.006. PMID:37730160. IF:(Q/D).
21/08/2023
Cost-effectiveness of apixaban and rivaroxaban in thromboprophylaxis of cancer patients treated with chemotherapy in Spain.
Muñoz AJ, Ortega L, Gutiérrez A, Gallardo E, Rubio-Rodríguez D, Rubio-Terrés C, Morón B, García-Alfonso P, Soria JM. Cost-effectiveness of apixaban and rivaroxaban in thromboprophylaxis of cancer patients treated with chemotherapy in Spain.. JOURNAL OF MEDICAL ECONOMICS. 2023; 26(1)DOI:10.1080/13696998.2023.2248839. PMID:37602646. IF:2.900(Q1/2D).
08/07/2021
Predictive Ability of a Clinical-Genetic Risk Score for Venous Thromboembolism in Northern and Southern European Populations.
Salas E, Farm M, Pich S, Onelöv L, Guillen K, Ortega I, Antovic JP, Soria JM. Predictive Ability of a Clinical-Genetic Risk Score for Venous Thromboembolism in Northern and Southern European Populations.. TH OPEN. 2021; 5(3)DOI:10.1055/s-0041-1729626. PMID:34263111. IF:(Q/D).
01/05/2026
Biosynthetic Prosthesis Omniflow II in Chronic-Limb Threatening Ischemia: Results of the Multicenter National Registry Omni-Femoropopliteal
Baturone, A, Serrano, FJ, Camblor, LA, Alonso, M, García, F, Rodríguez, M, Marquina, R, Egaña, JM, Lozano, C, Landaluce, M, Garzón, N, Miralles, M, Fité, J, Escudero, JR, Olmos, D, Gomez-Palonés, F, Ligero, JM, Martín, A. Biosynthetic Prosthesis Omniflow II in Chronic-Limb Threatening Ischemia: Results of the Multicenter National Registry Omni-Femoropopliteal. ANNALS OF VASCULAR SURGERY. 2026; 126DOI:10.1016/j.avsg.2025.12.037. PMID:41544849. IF:1.600(Q2/5D).
01/12/2025
Sources of essential lipids for Mycoplasma pneumoniae via P116 to target liver and atherosclerotic lesions
Vizarraga, D, Marcos, M, Rotllan, N, Martín, J, Santos, D, Camacho, M, Soto, B, Velasco-Reniu, L, Guerra, P, Pareja, F, Collantes, M, Wu, WL, Rodríguez-Arce, I, Serrano, L, Piñol, J, Fita, I, Escolà-Gil, JC. Sources of essential lipids for Mycoplasma pneumoniae via P116 to target liver and atherosclerotic lesions. Nature Communications. 2025; 16(1)DOI:10.1038/s41467-025-66129-5. PMID:41402265. IF:15.700(Q1/1D).
05/08/2025
Aortic Aneurysm Risk and the Somatic JAK2 V617F Mutation: Insights From a Multicenter, Population-Based Cardiovascular Screening Study
Obel, LM, Skovbo, JS, Diederichsen, ACP, Thomassen, M, Kjær, L, Larsen, MK, Knudsen, TA, Skov, V, Kruse, TA, Burton, M, Dembic, M, Wienecke, T, Sabater-Lleal, M, Gerke, O, Bruun, NE, Ellervik, C, Brabrand, M, Steffensen, FH, Frost, L, Lambrechtsen, J, Busk, M, Urbonaviciene, G, Egstrup, K, Karon, M, Feddersen, S, Rasmussen, LM, Hasselbalch, HC, Lindholt, JS. Aortic Aneurysm Risk and the Somatic JAK2 V617F Mutation: Insights From a Multicenter, Population-Based Cardiovascular Screening Study. CIRCULATION. 2025; 152(5)DOI:10.1161/CIRCULATIONAHA.125.074002. PMID:40464064. IF:38.600(Q1/1D).
01/07/2025
Targeting the pyruvate dehydrogenase kinase/pyruvate dehydrogenase axis modulates neutrophil and smooth muscle cell pathological responses and prevents abdominal aortic aneurysm formation
Griepke, S, Grentzmann, A, Tripodi, GL, Hansen, J, da Fonseca, MP, Nilsson, MD, Tallouzi, Y, Grupe, E, Jensen, PS, Beck, HC, Temprano-Sagrera, G, Sabater-Lleal, M, Burton, M, Dembic, M, Thomassen, M, Forteza, MJ, Terp, MG, Lindholt, JS, Rasmussen, LM, Steffensen, LB, Stubbe, J, Ketelhuth, DFJ. Targeting the pyruvate dehydrogenase kinase/pyruvate dehydrogenase axis modulates neutrophil and smooth muscle cell pathological responses and prevents abdominal aortic aneurysm formation. CARDIOVASCULAR RESEARCH. 2025; 121(8)DOI:10.1093/cvr/cvaf032. PMID:40037693. IF:13.300(Q1/1D).
25/12/2025
Insights into the causal role of diesel exhaust particles in ventricular arrhythmogenesis: protective effects of antioxidant cerium oxide nanoparticles
Ganse, FG, Ernst, LM, Rodríguez, C, Ruiz-Meana, M, Inserte, J, Martínez-González, J, Briones, AM, García-Redondo, AB, Consegal, M, Miro-Casas, E, Yáñez-Bisbe, L, Pomposo, A, Prades-Martínez, M, Ferreira-González, I, Puntes, V, Benito, B, Rodríguez-Sinovas, A. Insights into the causal role of diesel exhaust particles in ventricular arrhythmogenesis: protective effects of antioxidant cerium oxide nanoparticles. Particle and Fibre Toxicology. 2025; 22(1)DOI:10.1186/s12989-025-00649-2. PMID:41444986. IF:8.200(Q1/1D).
01/10/2025
VISUAL AND AUTOMATED COLLATERAL SCORING ON CT-ANGIOGRAPHY PREDICTS OUTCOME IN ACUTE ISCHEMIC STROKE PATIENTS UNDERGOING ENDOVASCULAR THERAPY
Martínez-González, J, Guasch-Jiménez, M, Martí-Fàbregas, J, Ortega-Quintanilla, J, Dinia, L, Branera, J, Villalba, J, Hernández-García, J, Guerrero, R, Ezcurra-Diaz, G, Lambea-Gil, A, Aguilera-Simon, A, Ramos-Pachon, A, Prats-Sanchez, L, Martinez-Domeño, A, Fernández-Vidal, JM, Camps-Renom, P. VISUAL AND AUTOMATED COLLATERAL SCORING ON CT-ANGIOGRAPHY PREDICTS OUTCOME IN ACUTE ISCHEMIC STROKE PATIENTS UNDERGOING ENDOVASCULAR THERAPY. International Journal of Stroke. 2025; 20DOI:. PMID:. IF:8.700(Q1/1D).
01/09/2025
Gender and socioeconomic inequalities in adolescent mental well-being in Barcelona: a repeated cross-sectional study
Olivella-Cirici, M, Vilagut, G, Sánchez-Ledesma, E, Serral, G, Cortés-Albaladejo, M, Cejas, PM, Pasarín, M, Alonso, J, Pérez, G. Gender and socioeconomic inequalities in adolescent mental well-being in Barcelona: a repeated cross-sectional study. Journal Of Public Health-Heidelberg. 2025; DOI:10.1007/s10389-025-02573-3. PMID:. IF:(Q/D).
31/03/2025
Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction
Briones, AM, Hernanz, R, García-Redondo, AB, Rodriguez, C, Blanco-Colio, LM, Val-Blasco, A, Alonso, MJ, Salaices, M. Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2025; 136(5)DOI:10.1111/bcpt.70026. PMID:40159875. IF:3.300(Q2/4D).
12/02/2024
Upregulation of NOR-1 in calcified human vascular tissues: impact on osteogenic differentiation and calcification.
Ballester-Servera C, Cañes L, Alonso J, Puertas-Umbert L, Vázquez-Sufuentes P, Taurón M, Roselló-Díez E, Marín F, Rodríguez C, Martínez-González J. Upregulation of NOR-1 in calcified human vascular tissues: impact on osteogenic differentiation and calcification.. Translational Research. 2024; 264DOI:10.1016/j.trsl.2023.09.004. PMID:37690706. IF:5.900(Q1/1D).
01/01/2022
Interferon stimulated gene 15 pathway is a novel mediator of endothelial dysfunction and aneurysms development in angiotensin II infused mice through increased oxidative stress.
González-Amor M, García-Redondo AB, Jorge I, Zalba G, Becares M, Ruiz-Rodríguez MJ, Rodríguez C, Bermeo H, Rodrigues-Díez R, Rios FJ, Montezano AC, Martínez-González J, Vázquez J, Redondo JM, Touyz RM, Guerra S, Salaices M, Briones AM. Interferon stimulated gene 15 pathway is a novel mediator of endothelial dysfunction and aneurysms development in angiotensin II infused mice through increased oxidative stress.. CARDIOVASCULAR RESEARCH. 2022; 118(16)DOI:10.1093/cvr/cvab321. PMID:34672341. IF:10.800(Q1/1D).
01/01/2026
Pharmacogenetics in refractory psychiatric disorders: Clinical utility in two consanguineous patients
Panisello-Cardona, M, da Silva, IM, Riera, P, Bernal, S, Almenta, D, Lechuga, MG. Pharmacogenetics in refractory psychiatric disorders: Clinical utility in two consanguineous patients. EUROPEAN JOURNAL OF PSYCHIATRY. 2026; 40(1)DOI:10.1016/j.ejpsy.2025.100335. PMID:. IF:1.500(Q3/7D).
01/11/2025
Clinicopathological and molecular features of recurrence in ctDNA-negative resected colorectal cancer
Beltran, JS, Pérez, MARSM, Manrique, ACV, Cullell, BM, Munoz, MN, Mateo, FJP, Riera, P, Fuste, V, Fumagalli, C, Szafranska, J, Catasus, L, Gonzalez, A, Paez, D. Clinicopathological and molecular features of recurrence in ctDNA-negative resected colorectal cancer. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.08.1344. PMID:. IF:65.400(Q1/1D).
01/09/2025
A recurrent non-coding 3'UTR variant as a hidden second hit in 11 families with CAPN3-related limb girdle muscular dystrophy
Estévez-Arias, B, Segarra-Casas, A, Romo, L, Polavarapu, K, O'Heir, E, Singer-Berk, M, O'Leary, M, Nectoux, J, Spinazzi, M, Leturcq, F, Llanso, L, Domínguez, C, Topf, A, Lochmüller, H, Malfatti, E, Nascimento, A, Gallardo, E, González-Quereda, L, Natera-de Benito, D. A recurrent non-coding 3'UTR variant as a hidden second hit in 11 families with CAPN3-related limb girdle muscular dystrophy. NEUROMUSCULAR DISORDERS. 2025; 53DOI:10.1016/j.nmd.2025.105786. PMID:. IF:2.800(Q2/5D).
01/07/2025
Response to the Letter to the Editor regarding "Persistence, effectiveness, and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies in patients with chronic migraine"
de Dios, A, Pagès-Puigdemont, N, Ojeda, S, Riera, P, Pelegrin, R, Morollon, N, Belvís, R, Real, J, Masip, M. Response to the Letter to the Editor regarding "Persistence, effectiveness, and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies in patients with chronic migraine". HEADACHE. 2025; 65(7)DOI:10.1111/head.14983. PMID:40668957. IF:4.000(Q1/2D).
01/06/2025
Comprehensive Clinical and Genetic Characterization of a Spanish Cohort of 22 Patients With Bainbridge-Ropers Syndrome
Trujillano, L, Valenzuela, I, Costa-Roger, M, Cusco, I, Fernandez-Alvarez, P, Cueto-Gonzalez, A, Lasa-Aranzasti, A, Masotto, B, Abuli, A, Codina-Sola, M, del Campo, M, Moreno, JAR, Dominguez, CP, Milla, CP, de la Fuente, RP, Quesada-Espinosa, JF, Nunez-Enamorado, N, Gener, B, Ballesta-Martinez, MJ, Brea-Fernandez, AJ, Fernandez-Prieto, M, Trujillo-Quintero, JP, Ruiz, A, Santos-Simarro, F, Rosello, M, Orellana, C, Martinez, F, Martinez-Monseny, AF, Casas-Alba, D, Serrano, M, Palomares-Bralo, M, Rikeros-Orozco, E, Gomez-Cano, MA, Tirado-Requero, P, Juste, JP, Ramos, FJ, Garcia-Arumi, E, Tizzano, EF. Comprehensive Clinical and Genetic Characterization of a Spanish Cohort of 22 Patients With Bainbridge-Ropers Syndrome. CLINICAL GENETICS. 2025; 107(6)DOI:10.1111/cge.14701. PMID:39833101. IF:2.300(Q3/6D).
15/01/2025
Clinical and imaging spectrum of non-congenital dominant ACTN2 myopathy
Iruzubieta, P, Verdú-Díaz, J, Töpf, A, Luce, L, Claeys, KG, De Ridder, W, González-Quereda, L, de la Hoz, CPD, Poza, JJ, Zulaica, M, de Jonghe, P, Duff, J, Mroczek, M, Martín-Jiménez, P, Hernández-Laín, A, Domínguez-González, C, Baets, J, Gallano, P, Díaz-Manera, J, Straub, V, de Munain, AL, Fernandez-Torron, R. Clinical and imaging spectrum of non-congenital dominant ACTN2 myopathy. JOURNAL OF NEUROLOGY. 2025; 272(2)DOI:10.1007/s00415-025-12893-9. PMID:39812845. IF:4.600(Q1/2D).
21/01/2025
Annexin A8 deficiency delays atherosclerosis progression
Gutiérrez-Muñoz, C, Blázquez-Serra, R, San Sebastian-Jaraba, I, Sanz-Andrea, S, Fernández-Gómez, MJ, Nuñez-Moreno, G, Mínguez, P, Escolá-Gil, JC, Nogales, P, Ollivier, V, Martín-Ventura, JL, Noe, BHT, Rescher, U, Méndez-Barbero, N, Blanco-Colio, LM. Annexin A8 deficiency delays atherosclerosis progression. Clinical and Translational Medicine. 2025; 15(1)DOI:10.1002/ctm2.70176. PMID:39835780. IF:6.800(Q1/2D).
01/10/2023
Comment on Huh et al. Remnant Cholesterol Is an Independent Predictor of Type 2 Diabetes: A Nationwide Population-Based Cohort Study. Diabetes Care 2023;46:305-312.
Canyelles M, Blanco-Vaca F, Pérez A, Escolà-Gil JC. Comment on Huh et al. Remnant Cholesterol Is an Independent Predictor of Type 2 Diabetes: A Nationwide Population-Based Cohort Study. Diabetes Care 2023;46:305-312.. DIABETES CARE. 2023; 46(10)DOI:10.2337/dc23-0774. PMID:37729500. IF:(Q/D).
01/11/2022
(1)H-magnetic resonance spectroscopy lipoprotein profile in patients with chronic heart failure versus matched controls.
Teis A, Castelblanco E, Cediel G, Amigó N, Julve J, Ribalta J, Guardiola M, Franch J, Bermúdez-López M, Codina P, Lupón J, Mauricio D, Alonso N, Bayés-Genís A. (1)H-magnetic resonance spectroscopy lipoprotein profile in patients with chronic heart failure versus matched controls.. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 75(11)DOI:10.1016/j.rec.2021.09.008. PMID:34716123. IF:(Q/D).
01/02/2026
Lipid metabolic alterations in cancer: Common pathophysiology with cardiovascular disease
Llena-Meler, M, Canfran-Duque, A, Madrigal-Matute, J, Rotllan, N. Lipid metabolic alterations in cancer: Common pathophysiology with cardiovascular disease. SEMINARS IN CANCER BIOLOGY. 2026; 119DOI:10.1016/j.semcancer.2026.01.003. PMID:41520912. IF:15.700(Q1/1D).
25/01/2026
In vivo inhibition of miR-125b-5p modulates monocyte trafficking through the CCR7 receptor and reduces atherosclerosis
Mallén, A, Rotllan, N, Griñán, R, Varela, C, Bertolino, E, Paloschi, V, Maegdefessel, L, Escolà-Gil, JC, Aran, JM, Sbraga, F, Blasco-Lucas, A, Torras, J, Navarro, E, Hueso, M. In vivo inhibition of miR-125b-5p modulates monocyte trafficking through the CCR7 receptor and reduces atherosclerosis. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY. 2026; 330(1)DOI:10.1152/ajpcell.00242.2025. PMID:41289597. IF:4.700(Q1/1D).
01/06/2025
Effects of Chronic High-Fat Diet and Pemafibrate Treatment on Stroke Outcomes
Chaparro-Cabanillas, N, Pedragosa, J, Núñez-Moyano, H, Escolà-Gil, JC, Planas, AM. Effects of Chronic High-Fat Diet and Pemafibrate Treatment on Stroke Outcomes. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2025; 45(1)DOI:. PMID:. IF:4.500(Q1/2D).
26/02/2025
A novel likely pathogenic germline variant in CDKN1B in a patient with MEN4 and medullary thyroid cancer
Mercè, F, Asla, Q, Illana, FJ, Victòria, F, Javier, HL, Marta, S, Iglesias, C, Webb, SM, Aulinas, A. A novel likely pathogenic germline variant in CDKN1B in a patient with MEN4 and medullary thyroid cancer. Familial Cancer. 2025; 24(1)DOI:10.1007/s10689-025-00449-9. PMID:40009226. IF:2.000(Q3/7D).
01/02/2026
Early portopulmonary hypertension predicts mortality in patients with cirrhosis: Insights from the PORTO-DETECT cohort
Téllez, L, Donate, J, Guerrero, A, Beraza, IA, San Martín, D, Alvarado, E, Echevarria, V, Puente, A, Zamora, J, Del Prado, S, Tenes, A, Balagué, G, Vidal, B, Geli, C, Rodriguez-Gandia, MA, Baiges, A, Brujats, A, Rodríguez, DLH, Sánchez, SFG, Fortea, JI, del Cerro, MJ, Villanueva, C, Garcia-Pagán, JC, Giráldez, A, Albillos, A. Early portopulmonary hypertension predicts mortality in patients with cirrhosis: Insights from the PORTO-DETECT cohort. JOURNAL OF HEPATOLOGY. 2026; 84(2)DOI:10.1016/j.jhep.2025.09.011. PMID:41076090. IF:33.000(Q1/1D).
15/12/2025
Clinical and immunologic characteristics of nonhematologic autoimmune disorders in chronic lymphocytic leukemia
Arguello-Tomas, M, Lynton-Pons, E, Albiol, N, Lopez-Ferrer, A, Sierra, J, Moga, E, Moreno, C. Clinical and immunologic characteristics of nonhematologic autoimmune disorders in chronic lymphocytic leukemia. CANCER. 2025; 131(24)DOI:10.1002/cncr.70216. PMID:41378669. IF:5.100(Q1/3D).
01/12/2025
Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis
Rudler, M, Gea, VH, Larrue, H, Bouzbib, C, Procopet, B, Baiges, A, Turon, F, Villanueva, C, Albillos, A, Tapias, EA, Gluud, LL, Praktiknjo, M, Genesca, J, Ventura-Cots, M, Villagrasa, A, Rodrigues, S, Mouri, S, Giráldez-Gallego, A, Ridaura, HM, Laleman, W, Bureau, C, Robic, MA, Hartl, L, Tellez, L, Zipprich, A, Canete, N, Sultanik, P, Deckmyn, O, Mandorfer, M, Senzolo, M, Schepis, F, Tripathi, D, Pagan, JCG, Thabut, D. Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis. Jhep Reports. 2025; 7(12)DOI:10.1016/j.jhepr.2025.101611. PMID:41362711. IF:7.500(Q1/2D).
01/12/2025
Baseline Plasma Protein Signatures and Differential Molecular Responses to Dupilumab in Atopic Dermatitis Patients
Serra, E, Cantó, E, Gely, C, Pont, M, Trincado, J, Crespo, M, Vidal, S, Puig, L. Baseline Plasma Protein Signatures and Differential Molecular Responses to Dupilumab in Atopic Dermatitis Patients. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2025; 145(12)DOI:. PMID:. IF:5.700(Q1/1D).
01/09/2025
Personalized dosing in MS: extended interval dosing of ocrelizumab, a real-world observational study
Martín-Aguilar, L, Blanco-Sanromán, N, Appiani, FE, Caballero-Avila, M, Vidal, N, Martínez-Martínez, L, Querol, L, Vidal-Jordana, A. Personalized dosing in MS: extended interval dosing of ocrelizumab, a real-world observational study. Multiple Sclerosis Journal. 2025; 31(3)DOI:. PMID:. IF:5.000(Q1/2D).
01/04/2025
Interplay of leucocyte-platelet complexes and clinical response to eltrombopag in immune thrombocytopenia patients
Osuna-Gómez, R, Zamora, C, Novelli, S, Garcia-Pallarols, F, Rodriguez, Y, Domingo, A, Canet, M, Olivera, P, Mulet, M, Cantó, E, Valcarcel, D, Sanchez-Gonzalez, B, Vidal, S. Interplay of leucocyte-platelet complexes and clinical response to eltrombopag in immune thrombocytopenia patients. BRITISH JOURNAL OF HAEMATOLOGY. 2025; 206(4)DOI:10.1111/bjh.19779. PMID:39327831. IF:3.800(Q1/3D).
01/01/2025
Risk scores predicting disease progression in early-stage CLL: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy
Arguello-Tomas, M, Mozas, P, Albiol, N, López-Esteban, M, Sierra, J, Nomdedéu, J, Martinez-Laperche, C, Moga, E, Piñeyroa, JA, Delgado, J, Osorio, S, Moreno, C. Risk scores predicting disease progression in early-stage CLL: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy. CANCER. 2025; 131(1)DOI:10.1002/cncr.35552. PMID:39264834. IF:5.100(Q1/3D).
04/04/2023
A multistrain probiotic increases the serum glutamine/glutamate ratio in patients with cirrhosis: a metabolomic analysis.
Laghi L, Román E, Lan Q, Nieto JC, Canalda-Baltrons A, Poca M, Sánchez-Rodríguez MB, Clària J, Alvarado E, Cuyàs B, Sánchez E, Vidal S, Guarner C, Escorsell À, Manichanh C, Soriano G. A multistrain probiotic increases the serum glutamine/glutamate ratio in patients with cirrhosis: a metabolomic analysis.. Hepatology Communications. 2023; 7(4)DOI:10.1097/HC9.0000000000000072. PMID:37026745. IF:5.600(Q1/2D).
01/02/2022
Mediators of lifestyle intervention effects on neonatal adiposity: are we missing a piece of the puzzle?
Lima, RA, Desoye, G, Simmons, D, van Poppel, MNM, Corcoy R., Adelantado J.M., Jelsma, Judith G.M.. Mediators of lifestyle intervention effects on neonatal adiposity: are we missing a piece of the puzzle?. PEDIATRIC RESEARCH. 2022; 91(3)DOI:10.1038/s41390-021-01450-5. PMID:33753890. IF:3.600(Q1/2D).
01/01/2024
Characteristics of women with type 2 diabetes and heart failure in Spain. The DIABET-IC study.
Rodríguez-Padial L, Pérez A, Anguita Sánchez M, Barrios V, Gimeno-Orna JA, Muñiz J. Characteristics of women with type 2 diabetes and heart failure in Spain. The DIABET-IC study.. Cardiology Journal. 2024; 31(1)DOI:10.5603/CJ.a2023.0016. PMID:36896635. IF:1.900(Q3/6D).
01/12/2023
Breastfeeding is associated with a delayed decrease in postprandial maternal glucose concentration.
Monroy G, Fernández C, Olmo R, Martínez MJ, DE Leiva A, Corcoy R. Breastfeeding is associated with a delayed decrease in postprandial maternal glucose concentration.. Minerva Endocrinology. 2023; 48(4)DOI:10.23736/S2724-6507.23.03962-3. PMID:37158811. IF:(Q/D).
01/11/2023
Severe hypertriglyceridemia prevalence at a primary care setting in Catalonia, Spain.
Ortega E, Vlacho B, Treserres RP, Mata-Cases M, Altes A, Mauricio D, Franch-Nadal J. Severe hypertriglyceridemia prevalence at a primary care setting in Catalonia, Spain.. Journal of Clinical Lipidology. 2023; 17(6)DOI:10.1016/j.jacl.2023.09.002. PMID:37741728. IF:(Q/D).